CLIC Sargent, the leading charity for children and young people with cancer, has welcomed plans for genetic testing research for child cancer patients.
The research aims to give scientists and doctors detailed genetic information about a child's tumour within a few weeks of diagnosis – helping them pick personalised and effective treatment drugs.
Dara de Burca, Director of Services at CLIC Sargent, said: “From our experience as the UK’s leading cancer charity for children, we know current childhood cancer treatment is often gruelling and can have dramatic and long-lasting side-effects.
We would support anything that means quicker, more personalised treatment and could lead to better long term outcomes for children with cancer.
This research could have a huge impact on children and young people with cancer and their families.
Being diagnosed with cancer is a frightening experience and the emotional, practical and financial implications of treatment are intensely challenging for the whole family. Treatment is often gruelling, happens many miles from home and can last for up to three years and, for many, the after-effects reach into adulthood.”
CLIC Sargent is the UK’s leading cancer charity for children and young people, and their families. We provide clinical, practical and emotional support to help them cope with cancer and get the most out of life. Last year CLIC Sargent supported 6,800 children and young people with cancer. For more information visit www.clicsargent.org.uk
About childhood cancer
Every day 10 children and young people in the UK are told they have cancer. Although eight in 10 will survive cancer, it is still the leading cause of death overall among children and young people in the UK.
Note to sub editors
Please note that the name ‘CLIC Sargent’ should not be abbreviated to CLIC, and that the word ‘CLIC’ should always appear in capitals, as above.